Abstract
Background: Chronic Myeloid Leukemia (CML) is a myeloproliferative disease caused by BCR-ABL oncoprotein. Tyrosine kinase inhibitors have been develop......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
